OpenAI Expands into Life Sciences

OpenAI's latest model, GPT-Rosalind, is trained on complex biological workflows and is intended to assist researchers in identifying new therapeutic targets.

The company is positioning the tool as a more secure and specialized alternative for high-value professional work in the healthcare and defense sectors.

This move coincides with the release of a new cybersecurity-focused model, GPT-5.4 Cyber, which is being rolled out to a limited group of verified professionals.

These developments highlight the intensifying race between major AI firms to dominate specialized industrial applications.